REPATHA
REPATHA
Approved
DIN Number
02446057
Drug Class
Human
Market Date
Sep 28, 2015
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02446057
AIG Number0157370001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
C10AX13 EVOLOCUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification24:06.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
EVOLOCUMABActive
Strength: 140 MG / ML
Monograph: EVOLOCUMAB